Cubist Systematic Strategies, LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Cubist Systematic Strategies, LLC

$14.3 Billion
Q2 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$144.95 - $152.29 $204,959 - $215,338	-1,414 Reduced 27.44%	3,740 $565,000
Q2 2022 Aug 15, 2022	SELL	$83.14 - $145.99 $701,036 - $1.23 Million	-8,432 Reduced 62.06%	5,154 $751,000
Q1 2022 May 16, 2022	BUY	$110.08 - $142.92 $984,225 - $1.28 Million	8,941 Added 192.49%	13,586 $1.61 Million
Q4 2021 Feb 14, 2022	BUY	$99.73 - $148.48 $463,245 - $689,689	4,645 New	4,645 $640,000
Q3 2021 Nov 15, 2021	SELL	$98.85 - $138.91 $961,513 - $1.35 Million	-9,727 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$65.78 - $105.02 $435,003 - $694,497	6,613 Added 212.36%	9,727 $944,000
Q1 2021 May 17, 2021	SELL	$64.07 - $91.75 $2.98 Million - $4.26 Million	-46,483 Reduced 93.72%	3,114 $213,000
Q4 2020 Feb 16, 2021	BUY	$65.07 - $98.24 $2.49 Million - $3.76 Million	38,284 Added 338.41%	49,597 $4.25 Million
Q3 2020 Nov 16, 2020	BUY	$59.04 - $77.95 $468,777 - $618,923	7,940 Added 235.4%	11,313 $735,000
Q2 2020 Aug 14, 2020	BUY	$29.01 - $74.23 $97,850 - $250,377	3,373 New	3,373 $247,000
Q1 2020 May 15, 2020	SELL	$27.51 - $57.29 $627,228 - $1.31 Million	-22,800 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$40.86 - $57.65 $931,608 - $1.31 Million	22,800 New	22,800 $1.24 Million
Q3 2019 Nov 14, 2019	SELL	$37.38 - $49.47 $257,323 - $340,551	-6,884 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$39.79 - $67.01 $225,092 - $379,075	5,657 Added 461.04%	6,884 $301,000
Q1 2019 May 15, 2019	SELL	$34.52 - $53.29 $789,196 - $1.22 Million	-22,862 Reduced 94.91%	1,227 $63,000
Q4 2018 Feb 14, 2019	BUY	$29.75 - $42.9 $141,312 - $203,775	4,750 Added 24.56%	24,089 $891,000
Q3 2018 Nov 14, 2018	BUY	$32.79 - $43.0 $340,229 - $446,168	10,376 Added 115.76%	19,339 $726,000
Q2 2018 Aug 14, 2018	BUY	$23.62 - $42.29 $211,706 - $379,045	8,963 New	8,963 $354,000
Q1 2018 May 15, 2018	SELL	$22.49 - $34.56 $280,945 - $431,723	-12,492 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$20.44 - $35.56 $255,336 - $444,215	12,492	12,492 $337,000

Others Institutions Holding BHVN

# of Institutions

Shares Held

785K

Call Options Held

Put Options Held

View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

More about BHVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account